I betragtning af, at valsartan givet alene er mindst lige så effektiv som captopril (en ACE- hæmmer) givet alene til nedbringelse af dødeligheden efter akut MI, godkendte CHMP dog den harmoniserede indikation:
But considering that valsartan given on its own is at least as effective as captopril (an ACE inhibitor) given on its own in the reduction of total mortality after an acute MI, the CHMP endorsed the harmonised indication: